OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
60
Results
Show all
Save search
Copy query
Show results for
Unknown
(60)
Release Date
2024
(11)
2023
(8)
2022
(8)
2021
(8)
2025
(7)
2020
(6)
2015
(4)
2019
(2)
2018
(2)
2017
(2)
2026
(1)
2014
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Targeted therapy for renal cell carcinoma: The next lap.
Not available
S-EPMC3986548
|
biostudies-literature
Cite
Quality of life of elderly patients with solid tumours undergoing adjuvant cancer therapy: a systematic review.
Not available
S-EPMC5786145
|
biostudies-literature
Cite
Efficacy and safety of therapies for advanced prostate cancer in Asia: Evidence from a systematic literature review.
Not available
S-EPMC9666834
|
biostudies-literature
Cite
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Not available
S-EPMC6476457
|
biostudies-literature
Cite
Mentoring stages: A study of undergraduate mentoring in palliative medicine in Singapore.
Not available
S-EPMC6481808
|
biostudies-literature
Cite
Immunotherapy in Older Adults With Cancer.
Not available
S-EPMC8260908
|
biostudies-literature
Cite
Protocol for a scoping review of digital health for older adults with cancer and their families.
Not available
S-EPMC7451461
|
biostudies-literature
Cite
Targeted Therapies in Older Adults With Solid Tumors.
Not available
S-EPMC8260907
|
biostudies-literature
Cite
A Single-Arm Phase 1b Study of Everolimus and Sunitinib in Patients With Advanced Renal Cell Carcinoma.
Not available
S-EPMC4754968
|
biostudies-literature
Cite
The relationship between hope, medical expenditure and survival among advanced cancer patients.
Not available
S-EPMC10242009
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets